They revealed that the anti-inflammatory and hypolipidemic activities of GTE during non-alcoholic steatohepatitis likely occur through an Nrf2-independent mechanism [45]. This evidence concerns the gene NFE2L2 and metabolic dysfunction-associated steatohepatitis.